SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235645-05-000004
Filing Date
2005-04-19
Accepted
2005-04-19 16:17:32
Documents
1
Period of Report
2005-04-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8586
  Complete submission text file 0001235645-05-000004.txt   10233
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 420 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address
MUELLER ALAN L (Reporting) CIK: 0001235645 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23272 | Film No.: 05759485